The Valley Desk

ArticleCancerPublished

Adjuvant platinum versus capecitabine for residual, invasive, triple-negative breast cancer: Patient-reported outcomes in ECOG-ACRIN EA1131

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
Cancer
Published
Subject terms
Humans; Neoplasm, Residual; Platinum; Chemotherapy, Adjuvant; Quality of Life; Adult; Aged; Middle Aged; Female; Triple Negative Breast Neoplasms; Capecitabine; Patient Reported Outcome Measures
PubMed ID
38236702
PubMed Central ID
PMC11078225
Added to directory
Source checked

Report a correction or request removal